Melatonin prevents oxidative stress resulting from iron and erythropoietin administration (Q43556349)

24 November 2017

title

Melatonin prevents oxidative stress resulting from iron and erythropoietin administration (English)

1 reference

24 November 2017

0 references

1 reference

Herrera J

1 reference

24 November 2017

Nava M

series ordinal

1 reference

24 November 2017

Romero F

series ordinal

1 reference

24 November 2017

Rodríguez-Iturbe B

series ordinal

1 reference

24 November 2017

publication date

1 April 2001

1 reference

American Journal of Kidney Diseases

24 November 2017

published in

1 reference

24 November 2017

1 reference

24 November 2017

1 reference

24 November 2017

page(s)

750-757

1 reference

Poor response to treatment of renal anaemia with erythropoietin corrected by iron given intravenously

24 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2801%2980124-4

7 January 2021

Recombinant human erythropoietin in anemic patients with end-stage renal disease. Results of a phase III multicenter clinical trial

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2801%2980124-4

7 January 2021

The anemia of chronic renal failure: pathophysiology and the effects of recombinant erythropoietin

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2801%2980124-4

7 January 2021

A randomized controlled study of iron supplementation in patients treated with erythropoietin

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2801%2980124-4

7 January 2021

Reduction in recombinant human erythropoietin doses by the use of chronic intravenous iron supplementation

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2801%2980124-4

7 January 2021

Economic appraisal of maintenance parenteral iron administration in treatment of anaemia in chronic haemodialysis patients

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2801%2980124-4

7 January 2021

Parenteral iron use in the management of anemia in end-stage renal disease patients

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2801%2980124-4

7 January 2021

Recombinant human erythropoietin enhances superoxide production by FMLP-stimulated polymorphonuclear leukocytes in hemodialysis patients

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2801%2980124-4

7 January 2021

Oxidative injury to erythrocytes, cell rigidity and splenic hemolysis in hemodialyzed patients before and during erythropoietin treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2801%2980124-4

7 January 2021

Effect of hemodialysis on lipid peroxidation and antioxidant system in patients with chronic renal failure

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2801%2980124-4

7 January 2021

Lipid peroxidation abnormalities in hemodialyzed patients

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2801%2980124-4

7 January 2021

Glutathione antioxidant system as a marker of oxidative stress in chronic renal failure

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2801%2980124-4

7 January 2021

Enhanced oxidative stress in haemodialysis patients receiving intravenous iron therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2801%2980124-4

7 January 2021

Melatonin attenuates acute renal failure and oxidative stress induced by mercuric chloride in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2801%2980124-4

7 January 2021

https://api.crossref.org/works/10.1016%2FS0272-6386%2801%2980124-4

1 reference

7 January 2021

Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2801%2980124-4

7 January 2021

Mycophenolate mofetil prevents the progressive renal failure induced by 5/6 renal ablation in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2801%2980124-4

7 January 2021

Free radicals and antioxidants: a personal view

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2801%2980124-4

7 January 2021

Glutathione peroxidase protein. Absence in selenium deficiency states and correlation with enzymatic activity

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2801%2980124-4

7 January 2021

Trace elements and lipid peroxidation abnormalities in patients with chronic renal failure

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2801%2980124-4

7 January 2021

Erythropoietin and oxidative stress in haemodialysis: beneficial effects of vitamin E supplementation

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2801%2980124-4

7 January 2021

Serum and erythrocyte tocopherol in uremic patients: effect of hemodialysis versus peritoneal dialysis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2801%2980124-4

7 January 2021

Ascorbic acid depletion in patients undergoing chronic hemodialysis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2801%2980124-4

7 January 2021

Water soluble vitamins in chronic hemodialysis patients and need for supplementation

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2801%2980124-4

7 January 2021

Does long-term treatment of renal anaemia with recombinant erythropoietin influence oxidative stress in haemodialysed patients?

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2801%2980124-4

7 January 2021

Reactive oxygen species production by monocytes and polymorphonuclear leukocytes during dialysis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2801%2980124-4

7 January 2021

Increased Lipid Peroxidation in Patients on Maintenance Hemodialysis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2801%2980124-4

7 January 2021

Lipoperoxidation in plasma and red blood cells of patients undergoing haemodialysis: vitamins A, E, and iron status

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2801%2980124-4

7 January 2021

Serum advanced glycosylation end products: a new class of uremic toxins?

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2801%2980124-4

7 January 2021

Advanced oxidation protein products as a novel marker of oxidative stress in uremia

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2801%2980124-4

7 January 2021

Enhanced LDL oxidation in uremic patients: an additional mechanism for accelerated atherosclerosis?

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2801%2980124-4

7 January 2021

Reduced erythrocyte defense mechanisms against free radical toxicity in patients with chronic renal failure

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2801%2980124-4

7 January 2021

Iron supplementation in haemodialysis--practical clinical guidelines

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2801%2980124-4

7 January 2021

Lipid peroxidation and antioxidant activity in chronic haemodialysis patients treated with recombinant human erythropoietin

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2801%2980124-4

7 January 2021

Lipid peroxidation and vitamin E in red blood cells and plasma in hemodialysis patients under rhEPO treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2801%2980124-4

7 January 2021

Melatonin in relation to cellular antioxidative defense mechanisms.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2801%2980124-4

7 January 2021

Pharmacological actions of melatonin in oxygen radical pathophysiology

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2801%2980124-4

7 January 2021

Antioxidant status of elderly chronic renal patients treated by continuous ambulatory peritoneal dialysis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2801%2980124-4

7 January 2021

Influence of dialysis on plasma lipid peroxidation products and antioxidant levels.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2801%2980124-4

7 January 2021

10.1016/S0272-6386(01)80124-4

Identifiers

DOI

1 reference

24 November 2017

1 reference